BMO Capital lowered the firm’s price target on TrueBlue to $15 from $20 but keeps an Outperform rating on the shares. The company’s Q3 earnings missed due to weaker-than-expected results in all three segments, though this was most pronounced in PeopleScout, the analyst tells investors in a research note. The firm adds however that while its May 2023 upgrade was premature, it also believes that trends will get less worse in subsequent quarters.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TBI: